Study on the relationship between serum neurotransmitter concentration and severity of disease in patients with breast cancer complicated with depression
-
Received Date:
2020-03-01
Accepted Date:
2020-09-10
-
Abstract
ObjectiveTo investigate the relationship between serum neurotransmitter concentration and severity of disease in patients with breast cancer complicated with depression.MethodsSixty breast cancer complicated with depression patients(SDS score ≥ 53 points) and 60 breast cancer complicated without depression patients(SDS score < 53 points) treated with adjuvant chemotherapy after radical mastectomy were divided into the observation group and control group, respectively.According to SDS score, the observation group was subdivided into the severe depression group(18 cases, SDS score ≥ 72 points), moderate depression group(20 cases, SDS score of 63 to 72 points) and mild depression group(22 cases, SDS score of 53 to 62 points).The levels of 5-hydroxytryptophan(5-HT), neuropeptide Y(NPY), dopamine(DA) and norepinephrine(NE) in peripheral blood in two groups were measured, and their relationship with the severity of depression in the observation group was observed.ResultsThe serum levels of 5-HT, DA, NPY and NE in observation group were significantly lower than those in control group(P < 0.01).The serum levels of 5-HT, DA, NPY and NE in severe depression group were lower than those in moderate depression group and mild depression group(P < 0.01), and the serum levels of 5-HT, DA, NPY and NE in moderate depression group were lower than those in mild depression group(P < 0.01).The serum levels of 5-HT, DA, NPY and NE in the observation group after anti-depression treatment significantly increased compared with before treatment(P < 0.01).The serum levels of 5-HT, DA, NPY and NE in breast cancer complicated with depression patients treated with chemotherapy after operation were negatively correlated with the SDS score(r=-0.575, -0.601, -0.568, -0.612, P < 0.01).ConclusionsThe serum neurotransmitter concentration decreases in breast cancer complicated with depression patients, and the neurotransmitter concentration is negatily correlated with the severity of depression.
-
-
References
[1]
|
杨敏, 兰波, 马飞, 等.乳腺癌术后辅助化疗患者焦虑抑郁的研究进展[J].临床肿瘤学杂志, 2019, 24(8):757. |
[2]
|
张立伟, 王苏妍, 高野, 等.负性注意偏向的神经递质基础:来自大鼠抑郁症模型的证据[J].中国医科大学学报, 2019, 48(9):807. |
[3]
|
陈俊, 方贻儒, 徐一峰.《2018版加拿大抑郁和焦虑治疗网络/国际双相障碍学会双相障碍管理指南》的更新重点解读[J].中国全科医学, 2019, 22(2):123. |
[4]
|
张娜, 孙元珏.乳腺癌筛查间期癌的研究进展[J].临床肿瘤学杂志, 2019, 24(10):954. |
[5]
|
王燕华, 杨如.化疗对年轻乳腺癌患者卵巢功能的影响及保护策略的研究进展[J].医学综述, 2019, 25(20):4024. |
[6]
|
杜娟, 马飞, 阮祥燕.乳腺癌患者生育力保护的研究进展[J].中国临床医生杂志, 2019, 47(7):769. |
[7]
|
俞玲红, 张秋华, 高秀飞.乳腺癌伴发抑郁症研究进展[J].浙江中医药大学学报, 2019, 43(4):387. |
[8]
|
BUSBY J, MILL K, ZHANG SD, et al.Selective serotonin reuptake inhibitor use and breast cancer survival:a population-based cohort study[J].Breast Cancer Res, 2018, 20(1):4. |
[9]
|
SALIBASIC M, DELIBEGOVIC S.The quality of life and degree of depression of patients suffering from breast cancer[J].Med Arch, 2018, 72(3):202. doi: 10.5455/medarh.2018.72.202-205 |
[10]
|
朱贤林, 王在平, 叶刚, 等.小剂量氯胺酮对抑郁大鼠海马Rac1蛋白表达及树突棘密度的影响[J].重庆医学, 2019, 48(18):3061. |
[11]
|
聂思茹, 张晓晔.乳腺癌患者焦虑抑郁的研究进展[J].现代肿瘤医学, 2019, 27(6):1080. |
[12]
|
李显, 姚建平, 封银曼, 等.老年抑郁与脑内单胺类神经递质关系的研究进展[J].中国中医药现代远程教育, 2018, 16(18):148. |
[13]
|
谢日华, 谢海艳, KREWSKI D, 等.血浆神经递质浓度与产后抑郁症的关系(英文)[J].中南大学学报(医学版), 2018, 43(3):274. |
[14]
|
林柳兵, 沈艳婷, 阙任烨, 等.疏肝健脾养心法对功能性消化不良伴焦虑抑郁状态患者血清5-HT、SP、VIP、NPY的影响[J].世界中西医结合杂志, 2019, 14(7):966. |
[15]
|
ENGE S, MOTHES H, FLEISCHHAUER M, et al.Genetic variation of dopamine and serotonin function modulates the feedback-related negativity during altruistic punishment[J].Sci Rep, 2017, 7(1):2996. doi: 10.1038/s41598-017-02594-3 |
-
-
Proportional views
-